PMGC (ELAB) vs Kairos Pharma (KAPA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Kairos Pharma is the larger company by market cap ($2.7 million vs $2.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELAB | KAPA |
|---|---|---|
| Share price | $3.08 | $0.8103 |
| Market cap | $2.49M | $2.74M |
| 1-day change | -0.96% | -15.55% |
| EPS (TTM) | $-1,731.49 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2,671.20 | $9.17 |
| 52-week low | $2.59 | $0.7827 |
| Distance from 52-week high | -99.88% | -91.16% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +5947.14% |
| Average volume | 127.38K | 613.04K |
| Shares outstanding | 809.58K | 3.39M |
| Employees | 32 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About PMGC
ELAB stock →PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
About Kairos Pharma
KAPA stock →Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
ELAB vs KAPA FAQ
Which is bigger, PMGC or Kairos Pharma?
Kairos Pharma (KAPA) is larger, with a market capitalization of $2.74M compared with $2.49M for PMGC (ELAB).
Are PMGC and Kairos Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.